Inflammasomes Assemble: Cytoplasmic Guardians or Fallen Heroes?
作者信息
Sinha Pratik, Calfee Carolyn S
机构信息
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine; and Department of Anesthesia, University of California, San Francisco, San Francisco, CA Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine; Department of Anesthesia; and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA.
出版信息
Crit Care Med. 2019 Aug;47(8):1161-1163. doi: 10.1097/CCM.0000000000003872.
Abstract
摘要
相似文献
1
Inflammasomes Assemble: Cytoplasmic Guardians or Fallen Heroes?
Crit Care Med. 2019 Aug;47(8):1161-1163. doi: 10.1097/CCM.0000000000003872.
2
Statin protects the heart against ischemia-reperfusion injury via inhibition of the NLRP3 inflammasome.
Int J Cardiol. 2017 Feb 15;229:23-24. doi: 10.1016/j.ijcard.2016.11.219. Epub 2016 Nov 9.
3
Biological insights from clinical trials and networks.
Am J Respir Crit Care Med. 2012 Mar 1;185(5):475-6. doi: 10.1164/rccm.201201-0047ED.
4
Statin-induced insulin resistance through inflammasome activation: sailing between Scylla and Charybdis.
Diabetes. 2014 Nov;63(11):3569-71. doi: 10.2337/db14-1059.
5
Inflammasomes: guardians of cytosolic sanctity.
Immunol Rev. 2009 Jan;227(1):95-105. doi: 10.1111/j.1600-065X.2008.00730.x.
6
NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.
Clin Sci (Lond). 2014 Feb;126(3):233-41. doi: 10.1042/CS20130043.
7
Inflammasome biology, molecular pathology and therapeutic implications.
Pharmacol Ther. 2018 Jul;187:133-149. doi: 10.1016/j.pharmthera.2018.02.011. Epub 2018 Feb 18.
8
Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Am J Respir Cell Mol Biol. 2016 Feb;54(2):151-60. doi: 10.1165/rcmb.2015-0231TR.
9
Inflammasomes in the Kidney.
Exp Suppl. 2018;108:177-210. doi: 10.1007/978-3-319-89390-7_8.
10
The authors reply.
Crit Care Med. 2020 Jan;48(1):e78. doi: 10.1097/CCM.0000000000004081.
引用本文的文献
1
Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury.
Am J Respir Crit Care Med. 2021 Jul 1;204(1):53-63. doi: 10.1164/rccm.202005-1916OC.
本文引用的文献
1
Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome.
Crit Care Med. 2019 Aug;47(8):1089-1096. doi: 10.1097/CCM.0000000000003816.
2
Phenotypes in acute respiratory distress syndrome: moving towards precision medicine.
Curr Opin Crit Care. 2019 Feb;25(1):12-20. doi: 10.1097/MCC.0000000000000571.
3
Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
Intensive Care Med. 2018 Nov;44(11):1859-1869. doi: 10.1007/s00134-018-5378-3. Epub 2018 Oct 5.
4
Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
Lancet Respir Med. 2018 Sep;6(9):691-698. doi: 10.1016/S2213-2600(18)30177-2. Epub 2018 Aug 2.
5
Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration.
Crit Care Med. 2018 Jan;46(1):21-28. doi: 10.1097/CCM.0000000000002749.
6
Inflammasomes: Key Mediators of Lung Immunity.
Annu Rev Physiol. 2017 Feb 10;79:471-494. doi: 10.1146/annurev-physiol-021115-105229.
7
Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Sci Rep. 2016 Dec 22;6:39473. doi: 10.1038/srep39473.
8
Simvastatin in the acute respiratory distress syndrome.
N Engl J Med. 2014 Oct 30;371(18):1695-703. doi: 10.1056/NEJMoa1403285. Epub 2014 Sep 30.
9
Rosuvastatin for sepsis-associated acute respiratory distress syndrome.
N Engl J Med. 2014 Jun 5;370(23):2191-200. doi: 10.1056/NEJMoa1401520. Epub 2014 May 18.
10
NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.
Clin Sci (Lond). 2014 Feb;126(3):233-41. doi: 10.1042/CS20130043.
Zotero 插件